As of September 2026, 333 paid clinical trials are recruiting in New Brunswick, New Jersey. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
New Brunswick offers studies at sites including Rutgers Cancer Institute of New Jersey for conditions such as Breast Cancer, Acute Myeloid Leukemia, Breast Neoplasms, Melanoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Researchers run research studies in New Brunswick, NJ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Rutgers Cancer Institute of New Jersey | Breast Cancer, Acute Myeloid Leukemia, Melanoma | 108 |
| Rutgers Cancer Institute | Bladder Cancer, Breast Cancer, Cancer | 36 |
| Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital | B Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Ganglioneuroblastoma, Nodular | 22 |
| Saint Peter's University Hospital | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Acute Lymphoblastic Leukemia | 22 |
| Rutgers Robert Wood Johnson Medical School | Opioid Use, Acute Otitis Media, Aortic Stenosis, Calcific | 18 |
| Robert Wood Johnson University Hospital | Aortic Valve Insufficiency, Aortic Valve Stenosis, AMI | 17 |
| Robert Wood Johnson Medical School | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 9 |
| Rutgers University | Advanced Breast Cancer, Aneurysm, Brain, Anxiety | 8 |
| RWJBarnabas Health - Robert Wood Johnson University Hospital | Cervical Cancer, Anal Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma | 6 |
| Rutgers Cancer Institute of New Jersey | Breast Cancer, Breast Neoplasms, Malignant Neoplasm | 6 |
| Rutgers | Advanced Urothelial Cancer, Aortoiliac Occlusive Disease, Breast Neoplasms | 5 |
| Rutgers - Robert Wood Johnson Medical School | Cystic Fibrosis, Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation | 4 |
| Cancer Institute of New Jersey | Anxiety, Caregiver Stress Syndrome, Metastases, Neoplasm | 4 |
| Rutgers, The State University of New Jersey | Cervical Cancer, Coagulation Disorder, Papilloma Viral Infection | 3 |
| Saint Peter's University Hospital - New Brunswick | Cerebroside Lipidosis Syndrome, Fabry Disease, Gaucher Disease | 3 |
| Ascentage Investigative | CML, CML, Chronic Phase, Chronic Myeloid Leukemia | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer | 2 |
| Clinical Trial Site | Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL), Relapsed/Refractory (R/R) Mature B Cell Non Hodgkin Lymphoma (NHL), Transthyretin Amyloidosis With Cardiomyopathy | 2 |
| GSK Investigational Site | Asthma, Neoplasms | 2 |
| Institute for Food, Nutrition, and Health | Type 2 Diabetes, Brain Blood Flow, Cognition | 2 |
| Jack & Sheryl Morris Cancer Center | Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma, Sickle Cell Disease | 2 |
| Robert Wood Johnson University Hospital Clinical Research Center | Type 2 Diabetes, Brain Blood Flow, Cognition | 2 |
| Rutgers Cancer Institute of NJ | Advanced Solid Malignancies, Endometrial Adenocarcinoma | 2 |
| Rutgers Health | Pancreatic Cystic Lesions, Triple Negative Breast Cancer | 2 |
| Rutgers University (Data Collection Only) | Hepatectomy, Malignant Mesothelioma, Malignant Peritoneal Mesothelioma | 2 |
Recruiting trials in New Brunswick grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 333 recruiting clinical trials in New Brunswick, New Jersey listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in New Brunswick compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in New Brunswick include Breast Cancer (14), Acute Myeloid Leukemia (10), Breast Neoplasms (7), Cancer (7), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in New Brunswick on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in New Brunswick include Rutgers Cancer Institute of New Jersey, Rutgers Cancer Institute, Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in New Brunswick are Cancer & tumors (174), Diabetes & metabolic (12), Neurology & pain (12). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.